Key statistics
As of last trade WAVE Life Sciences Ltd (WVE:NMQ) traded at 14.24, -14.94% below its 52-week high of 16.74, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.51 |
---|---|
High | 14.52 |
Low | 14.08 |
Bid | 14.22 |
Offer | 14.25 |
Previous close | 14.35 |
Average volume | 1.37m |
---|---|
Shares outstanding | 145.60m |
Free float | 122.67m |
P/E (TTM) | -- |
Market cap | 2.09bn USD |
EPS (TTM) | -1.11 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 19:36 GMT.
More ▼
- Wave Life Sciences to Present at Jefferies London Healthcare Conference
- Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
- Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024
- Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
- Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
- Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024
- Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
- Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
- Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
More ▼